Abstract
The aim of this project is to evaluate the efficacy of palladium-oxime complexes in targeting specific cellular organelles, such as lysosomes and mitochondria, to overcome drug resistance in bone tumors, particularly osteosarcomas. These tumors exhibit significant resistance to traditional drugs like cisplatin, doxorubicin, and methotrexate, presenting a major challenge in oncological tre…